Natural Killer Cell Technology
SCIENTIFIC ANIMATION | Investor Relations & Social Media Activities
The purpose of this animation is to educate viewers on Cytovia Therapeutics’ Natural Killer (NK) Cell Technology, discovering how they are harnessing the innate immune system with complementary and disruptive NK-cell and NK-engager antibody platforms.
The chapters take the viewer on the journey of the technology, starting with the manufacturing process of NK cells from induced pluripotent stem cells (iPSCs). The story then moves on to gene editing and how gene-edited iNK cells are developed. The remaining chapters cover Chimeric Antigen Receptors (CARs), master cell bank creation, cell bank differentiation and expansion, Flex-NK™ Cell Engagers, and finally, a summary scene of the NK revolution and Cytovia’s work against cancer and towards a cure.
Using vibrant, high-quality visuals the story of NK cells and their potential as cancer-combating therapies are brought to life in 3D. The animation was commissioned to support Cytovia’s investor relations activities, ensuring potential investors could understand and visualize the science behind this concept.
2D assets and imagery from the animation have been incorporated on Cytovia’s corporate website. Looping clips, video banners, and animation stills can be seen across the entire website, creating a consistent brand identity. Imagery is displayed throughout the ‘Our Technology’ page, illustrating each step of the journey to develop these therapies.
In addition, the animation has been used to enhance Cytovia’s social media activity, with the video being shared on Linkedin to allow viewers to learn more about what Cytovia does and the science behind their therapies.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen